Artivion Inc | CRY

Artivion Inc traded at $12.50 this Thursday January 26th, decreasing $0.19 or 1.50 percent since the previous trading session. Looking back, over the last four weeks, Artivion Inc lost 5.66 percent. Over the last 12 months, its price fell by 26.64 percent. Looking ahead, we forecast Artivion Inc to be priced at 12.28 by the end of this quarter and at 11.10 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
12.50
Daily Change
-1.50%
Yearly
-26.64%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Terumo 3,838.00 21.00 0.55% -4.60%
Abbott 110.88 -0.12 -0.11% -7.94%
AngioDynamics 12.94 0.08 0.58% -36.78%
Accuray 2.46 0.04 1.45% -28.84%
AtriCure 43.04 -0.03 -0.07% -27.53%
Baxter International 46.18 0.04 0.08% -45.44%
Becton, Dickinson and Co. 249.14 2.36 0.96% -0.82%
Boston Scientific 46.35 0.23 0.50% 7.22%
Artivion Inc 12.50 -0.19 -1.50% -26.64%
Cardiovascular Systems 13.49 -0.07 -0.52% -19.89%
Edwards Lifesciences 78.21 0.52 0.67% -23.29%
Integra LifeSciences 56.84 0.06 0.11% -9.58%
Inogen 22.78 0.42 1.88% -21.48%
J&J 168.93 -0.58 -0.34% -0.97%
Mesa Laboratories 193.68 6.17 3.29% -28.79%
Orthofix International 21.18 0.58 2.82% -28.88%
Pfizer 44.21 -0.88 -1.95% -17.16%
ResMed 232.22 1.06 0.46% 3.26%
Surmodics 26.13 -0.51 -1.91% -38.33%
Stryker 251.83 -1.12 -0.44% 2.65%
Teleflex 240.83 0.47 0.20% -18.52%
Tandem Diabetes Care 39.49 -0.40 -1.00% -64.48%
Trinity Biotech 1.15 0.06 5.50% -0.86%

Indexes Price Day Year
US2000 1903 4.13 0.22% -1.46%

Artivion Inc
CryoLife, Inc. (CryoLife), is a medical device company. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The Company operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as Surgical Sealants, BioGlue products, JOTEC products, On-X products, CardioGenesis cardiac laser therapy, PhotoFix, and NEXUS. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues.